Evidence map›Paper›PMID 40893032›Full record

ArticleChronic obstructive pulmonary diseases (Miami, Fla.)2025

Prospective COPD Case Finding in a Lung Cancer Screening Program: A Pilot Study.

Robert Spetrini, Paul Pikman, Vincent Kang, Jared Beaudin, Hana Rajevac, Karl Anderson, Nur Ay, Patrick Ottman, Katherine El-Tayeb, Lee Gazourian and 5 more

Abstract read
In one paragraph

Article in Chronic obstructive pulmonary diseases (Miami, Fla.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Robert SpetriniLahey Hospital and Medical Center, UMass Chan Medical School-Lahey, Burlington, Massachusetts, United States.
Paul PikmanLahey Hospital and Medical Center, UMass Chan Medical School-Lahey, Burlington, Massachusetts, United States.
Vincent KangLahey Hospital and Medical Center, UMass Chan Medical School-Lahey, Burlington, Massachusetts, United States.
Jared BeaudinLahey Hospital and Medical Center, UMass Chan Medical School-Lahey, Burlington, Massachusetts, United States.
Hana RajevacLahey Hospital and Medical Center, UMass Chan Medical School-Lahey, Burlington, Massachusetts, United States.
Karl AndersonLahey Hospital and Medical Center, UMass Chan Medical School-Lahey, Burlington, Massachusetts, United States.
Nur AyLahey Hospital and Medical Center, UMass Chan Medical School-Lahey, Burlington, Massachusetts, United States.
Patrick OttmanLahey Hospital and Medical Center, UMass Chan Medical School-Lahey, Burlington, Massachusetts, United States.
Katherine El-TayebTufts University School of Medicine, Boston, Massachusetts, United States.
Lee GazourianLahey Hospital and Medical Center, UMass Chan Medical School-Lahey, Burlington, Massachusetts, United States.
Yuxiu LeiLahey Hospital and Medical Center, UMass Chan Medical School-Lahey, Burlington, Massachusetts, United States.
Anthony CampagnaLahey Hospital and Medical Center, UMass Chan Medical School-Lahey, Burlington, Massachusetts, United States.
Richard ThomasLahey Hospital and Medical Center, UMass Chan Medical School-Lahey, Burlington, Massachusetts, United States.
Batolome CelliBrigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, United States.
Victor Pinto-PlataLahey Hospital and Medical Center, UMass Chan Medical School-Lahey, Burlington, Massachusetts, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Chronic obstructive pulmonary disease (COPD) remains underdiagnosed and undertreated. Because screening asymptomatic individuals for COPD is not recommended, several case-finding tools have been explored. The COPD Assessment in Primary Care to Identify Undiagnosed Respiratory Disease and Exacerbation Risk (CAPTURE) questionnaire and peak expiratory flow (PEF) rate (CAPTURE tool) have been tested in the primary care setting, with disappointing results. We hypothesized that these tools could yield better results in a computed tomography lung screening (CTLS) program, where individuals have a history of cigarette smoking and higher prevalence of COPD. Methods: We recruited 67 patients referred to a CTLS program at a single institution. Participants completed the CAPTURE and COPD Assessment Test (CAT) questionnaires. Spirometric testing was completed with a portable device and low-dose chest computed tomography (CT) was performed according to a standard protocol. Results: The group's mean age was 66 ±7 years, 43% were male, with a 37 pack-year smoking history. Eighteen (27%) had COPD (forced expiratory volume in 1 second of 60 ±22% predicted) and a higher CAT score (12 [interquartile range (IQR) 6-15]) compared to the nonobstructed group (CAT=7 [IQR 3-10]), Conclusions: The CAPTURE tool is an effective method to find COPD cases in lung cancer screenings. A CT diagnosis of emphysema can substitute peak flow in this population.

Indexed as

case identificationCOPDCOPD Assessment Testlung cancer screeningsunderdiagnosis

Identifiers

PMID40893032
PMCPMC12614182

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.